Global /United States /Healthcare /Medical Care Facilities /BTMD
chevron_leftBack
biote Corp. logo

biote Corp.

BTMD
NASDAQ: BTMD Delayed
2.22USD -1.3%
As of 13 June 2026, biote Corp. has a market cap of $82.73M USD, ranking #26883 globally and #4085 in the United States. It ranks #2408 in the Healthcare sector, and #285 in the Medical Care Facilities industry.
Global Rank
26883
Country Rank
4085
Sector Rank
2408
Industry Rank
285
Key Stats
Market Cap
$82.73MUSD
Enterprise Value
$169.65MUSD
Revenue (TTM)
$192.22MUSD
EBITDA (TTM)
$37.54MUSD
Net Income (TTM)
$27.05MUSD
EBITDA Margin
20%
Profit Margin
14%
PE Ratio
3.0
Forward PE
9.7
PS Ratio
0.4
EV/EBITDA
4.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Bret Christensen open_in_new
Employees
223
Founded
2012
Website
biote.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.3% -0.9% 68% 7.2% -19% -36%

News

Loading...

BTMD Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
BTMD
Biote Corp
ISIN: US0906831039
Shares Out.:
30.331M1 Shares Float: 27.483M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
2.22 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About biote Corp.

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.

Similar Companies

Industry: Medical Care Facilities (United States)
Name
Market Cap diff.
PE
$96.73B
117K%
14.9
$21.13B
25K%
24.6
$15.78B
19K%
11.6
SOLV
$11.53B
14K%
7.5
ENSG
$10.89B
13K%
31.9
$10.25B
12K%
6.8
Industry: Medical Care Facilities (Global)
Name
Market Cap diff.
PE
$232.18B
852.82B AED
281K%
44.1
$26.55B
22.97B EUR
32K%
15.0
$25.45B
22.02B EUR
31K%
24.9
$22.48B
84.42B SAR
27K%
35.2
$19.14B
77.85B MYR
23K%
37.0
$16.69B
84.79B BRL
20K%
18.1
chevron_leftBack